FDA Approves PROMETRIUM — Acertis Pharmaceuticals, LLC

# FDA Approves Progesterone Oral Formulation for Acertis Pharmaceuticals Acertis Pharmaceuticals, LLC has received FDA approval for PROMETRIUM (progesterone oral capsules), expanding the company's portfolio in women's health and establishing a key branded product in the progesterone replacement therapy market. The approval positions Acertis to capture significant market share in hormone replacement therapy, particularly among patients requiring oral progesterone supplementation for menopausal symptom management and pregnancy support.